Publicacións nas que colabora con Francisco Blanco García (23)

2024

  1. An exploratory analysis of associations of genetic variation with the efficacy of tocilizumab in severe COVID-19 patients. A pharmacogenetic study based on next-generation sequencing

    Frontiers in Pharmacology, Vol. 15

  2. Metabolic syndrome is not associated with erosive hand osteoarthritis: a cross-sectional study using data from the PROCOAC cohort

    Scientific Reports, Vol. 14, Núm. 1

  3. Mitonuclear epistasis involving TP63 and haplogroup Uk: Risk of rapid progression of knee OA in patients from the OAI

    Osteoarthritis and Cartilage, Vol. 32, Núm. 5, pp. 526-534

  4. Prognostic model to predict the incidence of radiographic knee osteoarthritis

    Annals of the Rheumatic Diseases, Vol. 83, Núm. 5, pp. 661-668

2023

  1. A meta-analysis and a functional study support the influence of mtDNA variant m.16519C on the risk of rapid progression of knee osteoarthritis

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 7, pp. 974-984

2022

  1. PROCOAC (PROspective COhort of A Coruña) description: Spanish prospective cohort to study osteoarthritis

    Reumatologia Clinica, Vol. 18, Núm. 2, pp. 100-104

  2. mtDNA haplogroup A enhances the effect of obesity on the risk of knee OA in a Mexican population

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. A clinical model including protein biomarkers predicts radiographic knee osteoarthritis: a prospective study using data from the Osteoarthritis Initiative

    Osteoarthritis and Cartilage, Vol. 29, Núm. 8, pp. 1147-1154

  2. Optical biomarkers for the diagnosis of osteoarthritis through raman spectroscopy: Radiological and biochemical validation using ex vivo human cartilage samples

    Diagnostics, Vol. 11, Núm. 3

2019

  1. Discovery of an autoantibody signature for the early diagnosis of knee osteoarthritis: Data from the Osteoarthritis Initiative

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 12, pp. 1699-1705

2017

  1. A replication study and meta-analysis of mitochondrial DNA variants in the radiographic progression of knee osteoarthritis

    Rheumatology (United Kingdom), Vol. 56, Núm. 2, pp. 263-270

  2. Mitochondrial DNA haplogroups influence the risk of incident knee osteoarthritis in OAI and CHECK cohorts. A meta-Analysis and functional study

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 6, pp. 1114-1122

  3. Plasma mitochondrial DNA levels are inversely associated with HIV-RNA levels and directly with CD4 counts: Potential role as a biomarker of HIV replication

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 11, pp. 3159-3162

2016

  1. European mitochondrial haplogroups impact on liver fibrosis progression among HCV and HIV/HCV-coinfected patients from Northwest Spain

    Journal of Acquired Immune Deficiency Syndromes, Vol. 73, Núm. 2, pp. 149-153

2015

  1. Mitochondrial DNA haplogroups modulate the radiographic progression of Spanish patients with osteoarthritis

    Rheumatology International, Vol. 35, Núm. 2, pp. 337-344

2014

  1. Individual telomere length decay in patients with spondyloarthritis

    Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 765, pp. 1-5

  2. Mitochondrial DNA (mtDNA) haplogroups influence the progression of knee osteoarthritis.Data from the osteoarthritis initiative (OAI)

    PLoS ONE, Vol. 9, Núm. 11

2012

  1. Mitochondrial haplogroups define two phenotypes of osteoarthritis

    Frontiers in Physiology, Vol. 3 MAY

2011

  1. Mitochondrial DNA (mtDNA) haplogroups and serum levels of anti-oxidant enzymes in patients with osteoarthritis

    BMC Musculoskeletal Disorders, Vol. 12

  2. Mitochondrial DNA haplogroups and serum levels of proteolytic enzymes in patients with osteoarthritis

    Annals of the Rheumatic Diseases, Vol. 70, Núm. 4, pp. 646-652